New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2013
11:57 EDTCTIC, AMAT, BSBR, RPRXHigh option volume stocks; AMAT RPRX BSBR CTIC
News For AMAT;RPRX;BSBR;CTIC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 13, 2014
16:27 EDTAMATApplied Materials down about 3% following Q4 results, guidance
Subscribe for More Information
16:04 EDTAMATApplied Materials reports backlog $2.92B at Q4 end, down 2% sequentially
Subscribe for More Information
16:03 EDTAMATApplied Materials reports Q4 adjusted gross margin 44.2%, up 220bps YoY
Subscribe for More Information
16:03 EDTAMATApplied Materials sees Q1 adjusted EPS 25c-29c, consensus 31c
Sees Q1 revenue in the range of flat to up 5% from the previous quarter. Q1 consensus $2.37B.
16:02 EDTAMATApplied Materials reports Q4 adjusted EPS 27c, consensus 27c
Reports Q4 revenue $2.26B, consensus $2.27B.
15:18 EDTAMATNotable companies reporting after market close
Subscribe for More Information
14:33 EDTAMATApplied Materials technical remarks before results
The shares have outperformed the broader averages in the last three months, trading up over 7%. We need to pull back to a longer time frame to get a clearer idea of the levels that could impact price following earnings. The most critical level is on the upside at $23. This area has been touched several times since May, but there hasn't been a strong enough fundamental catalyst to push the shares higher. If the news is stronger than already bullish expectations for the shares, a breakout above $23 would seem very likely. The 52-week high at $23.64 would also likely be taken out. Next resistance levels to watch as potential upside objectives would be at $24.32 and $25.94. The latter level hasn't been seen in over ten years. If the news isn't up to bullish expectations then the $21 level would be a first probable downside test. The $20 and $19 areas would be additional downside objectives with $19 having been important support over the course of the year.
13:32 EDTCTICLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTCTICLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTCTICLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
10:44 EDTRPRXOptions with decreasing implied volatility
Subscribe for More Information
10:01 EDTAMATOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
04:31 EDTAMATApplied Materials upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
November 12, 2014
14:19 EDTAMATApplied Material volatility elevated into Q4 and holiday outlook
Subscribe for More Information
10:34 EDTRPRXOptions with decreasing implied volatility
Options with decreasing implied volatility: RMTI RPRX KATE PNK CZR KING TSLA UBNT LOCO GNRC
November 11, 2014
16:14 EDTCTICLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including JAK inhibitors, novel Jakafi combinations for Myelofibrosis and developing compounds on an Analyst/Industry conference call to be held on November 17 at 10 am.
16:01 EDTAMATOptions Update; November 11, 2014
Subscribe for More Information
10:39 EDTRPRXOptions with decreasing implied volatility
Subscribe for More Information
November 10, 2014
10:17 EDTRPRXOptions with decreasing implied volatility
Options with decreasing implied volatility: RMTI ACHN RPRX ARCP SALE ZU KING UBNT KATE AWAY
09:04 EDTRPRXRepros Therapeutics reports Q3 EPS 32c, consensus (39c)
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use